We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
A technique which enabled light microscopy to produce an in-focus image of a three-dimensional structure at all depths would be extremely valuable.
In March 2006 Geron Corporation entered into a worldwide exclusive licence agreement covering patent applications describing a method for generating dendritic cells from human embryonic stem cells. In a linked research agreement, Geron will fund work in the University’s Sir William Dunn School of Pathology to further develop the technology under the guidance of Dr. Paul Fairchild and Professor Herman Waldmann.
Oxford University Innovation Ltd, the leading technology transfer company, has been granted its 100th Patent from the US Patent Office.
A paper appearing in EMBC¹ reports a major advance in the study of sleep disorders. Oxford BioSignals, a spin-out company from Oxford University, has developed and validated BioSleep, a novel system based on neural network analysis, which not only elucidates the microstructure of sleep - fleeting changes which have never before been consistently demonstrated - but also reliably detects abnormal sleep patterns.
Isis is partnering with the Carbon Trust to create a clean energy incubator whose purpose is to increase the likelihood of successfully commercialising technologies with carbon saving potential.
The 64th spin-out company from the University of Oxford, OxTox Ltd, will produce drug-testing kits for the police to use on drivers that are as reliable and easy to use as breathalysers for alcohol.
Oxonica has been named one of four nanotechnology startups offering the greatest value for potential corporate partners.
In April Oxitec announced that the US Department of Agriculture Biotechnology Regulatory Service has granted a permit for the release of sterile, genetically marked pink bollworm in up to 120 acres of commercial cotton in Arizona in the summer of 2007.
Zyentia Ltd, Oxford University's latest spin-out company from the Chemistry Department, the third within the last half year, is based on technology that has the potential to solve major problems in protein therapies.
A new company called TΔS (TDeltaS Ltd) has been spun-out of the University of Oxford based on findings made during research into human metabolism by Professor Kieran Clarke in the Department of Physiology, Anatomy and Genetics.
